Pharmacokinetics of a discontinuous absorption process of oxolinic acid in turbot, Scophthalmus maximus, after a single oral administration

References

• BARNES, A. C., LEWIN, C. S., HASTING, T. S. and AMYES, S. G. B. 1992, Bacterial activity of quinolone, including flumequine, against Aeromonas salmonicida. In D. J. Alderman and C. Michel (eds), Chemotherapy in Aquaculture: From Theory to Reality (Paris: Office International des Epizooties), pp. 326-332. 13.16 EKLUND H. V. and BYLUND, G. 1991, Comparative pharmacokinetics and bioavailability of oxolinic acid and oxytetracycline in rainbow trout (Oncorhynchus mykiss). Xenobiotica, 21, 1511-1520. Bki EKLUND H. V., ERIKSSON, A. and BYLUND, G. 1992, Temperature-related absorption and excretion of oxolinic acid in rainbow trout (Oncorhynchus mykiss). Aquaculture, 102, 17–27.
   Google Scholar
• Duis, K., HAMMER, C., BEVERIDGE, M. C. M., INGLIS, V. and BRAUM, E. 1995, Delivery of quinolone antibacterials to turbot, Scophthalmus maximus (L.), via bioencapsulation: quantification and efficacy trial. Journal of Fish Diseases, 18, 229–238.
   Google Scholar
• ENDO, T. 1992, Comparison of the bioavailability of micronized oxolinic acid in several animals including fish. In D. J. Alderman and C. Michel (eds), Chemotherapy in Aquaculture: From Theory to Reality (Paris: Office International des Epizooties), pp. 456–460.
   Google Scholar
• FANGE, R. and GROVE, D. 1979, Digestion. In W. S. Hoar, D. J. Randall and J. R. Brett (eds), Fish Physiology (London: Academic Press), vol. 8, ch. 4, pp. 161–260.
   Google Scholar
• GIBALDI, M. and PERRIER, D. 1982, Drugs and the Pharmaceutical Sciences. In Pharmacokinetics, 2nd edn, vol. 15 (New York: Marcel Dekker).
   Google Scholar
• GILES, J. S., HARIHARAN, H. and HEANEY, S. B. 1991, Evaluation of six antimicrobial agents against fish pathogenic isolates of V ibrio anguillarum, V zbrio ordalii and Aeromonas salmonicida. Bulletin of the Aquaculture Association of Canada, 3, 53–55.
   Google Scholar
• GOGNY M., BLANC, G. and GERARD, J. P. 1990, L'antibiotherapie chez les poissons. Recueil de Med ecine V eterinaire, 166, 355–360.
   Google Scholar
• GRANT, A. N. and LAIDLER, L. A. 1993, Assessment of antimicrobial sensitivity of Aeromonas salmonicida isolates from farmed Atlantic salmon in Scotland. Veterinary Record, 133, 389–391.
   PubMed Web of Science ®Google Scholar
• GUE.RIN -FAUBLE.E, V., DELIGNETTE -MULLER, M., VIGNEULLE, M. and FLAND ROIS, J.-P. 1996, Application of a modified disc diffusion technique to antimicrobial susceptibility testing of V zbrio anguillarum and Aeromonas salmonicida clinical isolates. Veterinary Microbiology, 51, 137–149.
   Google Scholar
• HORSBERG, T. E. 1994, Experimental methods for pharmacokinetic studies in salmonids. Annual Review of Fish Diseases, 4, 345–358.
   Google Scholar
• HUSTVEDT, S. 0., SALTE, R. and VASSVIK, V. 1991a, Absorption, distribution and elimination of oxolinic acid in Atlantic salmon (Salmo salar L.) after various routes of administration. Aquaculture, 95, 193–199.
   Google Scholar
• HUSTVEDT, S. 0., SALTE, R., KVENDSET 0. and VASSVIK, V. 1991b, Bioavailability of oxolinic acid in Atlantic salmon (Salmo salar L.) from medicated feed. Aquaculture, 97, 305–310.
   Google Scholar
• INGLIS, V. and RICHARDS, R. H. 1991, The in vitro susceptibility of Aeromonas salmonicida and other fish-pathogenic bacteria to 29 antimicrobial agents. Journal of fish diseases, 14, 641–650.
   Web of Science ®Google Scholar
• ISHIDA, N. 1992, Tissues levels of oxolinic acid after oral or intravascular administration to freshwater and seawater rainbow trout. Aquaculture, 102, 9–15.
   Web of Science ®Google Scholar
• KLEINOW, K. M., JARBOE, H. H. and SHOEMAKER, E. 1994, Comparative pharmacokinetics and bioavailibility of oxolinic acid in channel catfish (Ictalurus punctatus) and rainbow trout (Oncorhynchus mykiss). Canadian Journal of Fisheries and Aquatic Sciences, 51, 1205–1211.
   Web of Science ®Google Scholar
• KOVEN, V. M., HENDERSON, R. J. and SARGENT, J. R. 1997, Lipid digestion in turbot (Scophthalmus maximus): in vivo and in vitro studies of the lipolytic activity in various segments of the digestive tract. Aquaculture, 151, 155–171.
   Web of Science ®Google Scholar
• LEDO, A., DOPAZO, C. P., ROMALDE, J. L., TORANZO, A. E. and BARJA, J. L. 1987, Effectiveness of different chemotherapeutic agents for controlling bacterial fish diseases. Bulletin of European Association of Fish Pathology, 7, 655–671.
   Google Scholar
• MARTINSEN, B. and HORSBERG, T. E. 1995, Comparative single dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic salmon (Salmo salar) held in seawater at 10 °C. Antimicrobial Agents and Chemotherapy, 39, 1059–1064.
   PubMed Web of Science ®Google Scholar
• MARTINSEN, B., OPPEGAARD, H., WICHSTROM, R. and MYHR, E. 1992, Temperature-dependent in vitro antimicrobial activity of four 4-quinolones and oxytetracycline against bacteria pathogenic to fish. Antimicrobial Agents and Chemotherapy, 36, 1738–1743.
   Web of Science ®Google Scholar
• O'GRADY, P. and SMITH, P. 1992, Clinical significance of low levels of resistance to oxolinic acid in Aeromonas salmonicida. Bulletin of European Association of Fish Pathology, 12, 198–200.
   Google Scholar
• OGUMA, T., SHIMAMURA, K., USHIO, Y., YAMADA, H., TAKAHASHI, K., MURANUSHI, N., YOSHIKAWA, T., NAKASHIMA, M. and UEMATSU, T. 1990, Pharmacokinetic analysis of discontinuous absorption process of ceftibuten in humans. International Journal of Pharmaceutics, 63, 101–111.
   Web of Science ®Google Scholar
• PALMER, R., KAWAI, K. and KASUDA, R. 1992, In vitro activity of quinolone antibacterials against selected fish pathogens. Gyobyo kenkyu, 27, 131–142.
   Google Scholar
• POHER, I., BLANC, G. and LOUSSOUARN, S. 1997, Pharmacokinetics of oxolinic acid in sea-bass, Dicentrarchus labrax (L. 1758), after a single rapid intravascular injection. Journal of Veterinary Pharmacology and Therapeutics, 20, 267–275.
   PubMed Web of Science ®Google Scholar
• POULIQUEN, H., ARMAND, F. and LOUSSOUARN, S. 1997, Simple and rapid method for determination of oxolinic acid in Turbot (Scophthalmus maximus) serum by HPLC and fluorescence detection. Journal of Liquid Chromatography Biomedical Applications, 702, 157–162.
   PubMed Web of Science ®Google Scholar
• RICHARD, R. H., INGLE, V., FRERICHS, G. N. and MILLAR, S. D. 1992, Variation in antibiotic resistance patterns of Aeromonas salmonicida isolated from Atlantic Salmo salar L in Scotland. In D. J. Alderman and C. Michel (eds), Chemotherapy in Aquaculture: From Theory to Reality (Paris: Office International des Epizooties), pp. 276–287.
   Google Scholar
• RODGERS, C. J. and AUSTIN, B. 1983, Oxolinic acid for control of enteric redmouth disease in rainbow trout. Veterinary Record, 112, 83.
   PubMed Web of Science ®Google Scholar
• ROGSTAD, A., ELLINGSEN, 0. F. and SYVERTSEN, C. 1993, Pharmacokinetics and bioavailability of flumequine and oxolinic acid after various routes of administration to Atlantic salmon in seawater. Aquaculture, 110, 207–220.
   Google Scholar
• SATO, H., SATO, S., WANG, Y. M. and HORIKOSH I. 1996, Add-in macros for rapid and versatile calculation of non-compartment pharmacokinetic parameters on Microsoft Excel spreadsheets. Computer methods and Programs in Biomedicine, 50, 43–52.
   PubMed Web of Science ®Google Scholar
• SCHERRER, B. 1984, Biostatistique (Quebec, Canada: Gaitan morin).
   Google Scholar
• SCHLOTFELDT, H. J. 1992, Current practices of chemotherapy in fish culture. In Chemotherapy in aquaculture: from theory to reality, edited by D. J. Alderman and C. Michel (Paris: Office International des Epizooties), pp. 25–38.
   Google Scholar
• SHARGEL, L. and Yu, A. B. C. 1985, Applied Biopharmaceutics and Pharmacokinetics. 2nd edn (Norwalk: Appleton Century Crofts).
   Google Scholar
• STAMM, J. 1992, In vitro activity and resistance development for sarafloxacin (A-56620): an aquaculture antibacterial. In D. J. Alderman and C. Michel (eds). Chemotherapy in Aquaculture: From Theory to Reality (Paris: Office International des Epizooties), pp. 333–339.
   Google Scholar
• STOFFREGEN, D. A., WOOSTER, G. A., BUSTOS, P. S., BOWSER, P. R. and BABISH, J. G. 1997, Multiple route and dose pharmacokinetics of enrofloxacin in juvenile Atlantic salmon. Journal of Veterinary Pharmacology and Therapeutics, 20, 111–123.
   PubMed Web of Science ®Google Scholar
• TORENZO, A. E. and BARJA, J. L. 1992. First report of furunculosis in turbot reared in floating cages in northwest of Spain. Bulletin of European Association of Fish Pathology, 12, 147–149.
   Google Scholar
• TORENZO, A. E., ROMALDE, J. L., BAND IN, I., SANTOS, Y. and BARJA, J. L. 1992, Evaluation of the sensitivity of bacterial fish pathogens to different antimicrobial compounds. In D. J. Alderman and C. Michel (eds), Chemotherapy in Aquaculture: From Theory to Reality (Paris: Office International des Epizooties), pp. 315–325.
   Google Scholar
• TSOUMAS, A., ALDERMAN, D. J. and RODGERS, C. J. 1989, Aercmlonas salmonicida: development of resistance to 4-quinolone antimicrobials. Journal of fish diseases, 12, 493–507.
   Web of Science ®Google Scholar
• UENO, R., HORIGUCHI, Y. and KUBOTA, S. S. 1988a, Levels of oxolinic acid in cultured yellowtail after oral administration. Nippon Suisan Gakkaishi, 54, 479–484.
   Web of Science ®Google Scholar
• UENO, R., OKUMURA, M., HORIGUCHI, Y. and KUBOTA, S. S. 1988b, Levels of oxolinic acid in cultured rainbow trout and amaggo salmon after oral administration. Nippon Suisan Gakkaishi, 54, 485–489.
   Web of Science ®Google Scholar
• WITCHER, J. W. and BOUDINOT, F. D. 1996, Applications and simulations of a discontinuous oral absorption pharmacokinetic model. Pharmaceutical Research, 13, 1720–1724.
   PubMed Web of Science ®Google Scholar
• YAMAOKA, K., NAKAGAWA, T. and UNO, T. 1978a, Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biophar-maceutics, 6, 165–175.
   PubMedGoogle Scholar
• YAMAOKA, K., NAKAGAWA, T. and UNO, T. 1978b, Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 6, 547–558.
   PubMedGoogle Scholar